http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107677825-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2017-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107677825-B
titleOfInvention A kind of tumor diagnosis composition for diagnosis of cervical cancer and the purposes for being used to prepare diagnostic kit
abstract The invention discloses a kind of tumor diagnosis compositions for diagnosis of cervical cancer and the purposes for being used to prepare diagnostic kit.When serum hemolysis phosphatidyl choline (18:2), phosphatidylinositols (20:4/0:0) or N- phenylpropyl alcohol acyl-L-Glutamine diagnosis differentiation cervical cancer patient and healthy volunteer is used alone, area (AUC) is below 0.7 under ROC curve;AUC can be improved to 0.945 when triple combination distinguishes cervical cancer patient and healthy volunteer for diagnosing.One skilled in the art will appreciate that area is between 1.0 and 0.5 under ROC curve, in the case where AUC > 0.5, AUC illustrates that diagnosis effect is better closer to 1.AUC has lower accuracy in 0.5-0.7, and AUC has certain accuracy in 0.7-0.9, and AUC has high accuracy at 0.9 or more.Therefore, serum hemolysis phosphatidyl choline (18:2), phosphatidylinositols (20:4/0:0) and N- phenylpropyl alcohol acyl-L-Glutamine can combine the diagnostic kit for being used to prepare diagnosing cervical.
priorityDate 2017-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016041013-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011072130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0136977-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311264
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ97VT7
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420458965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448540569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280523
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6082
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407693923
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44128246

Total number of triples: 33.